LENZ Therapeutics (LENZ) Current Leases (2021 - 2023)

LENZ Therapeutics (LENZ) has 3 years of Current Leases data on file, last reported at $285000.0 in Q4 2023.

• Current Leases for Q4 2023 came in at $285000.0, down 92.95% year-over-year; the trailing twelve-month figure through Dec 2023 was $285000.0 (down 92.95% YoY), and the FY2023 annual result was $285000.0, down 92.95% from the prior year.
• Current Leases retreated to $285000.0 in Q4 2023 per LENZ's latest filing, from $3.4 million in the prior quarter.
• Over five years, Current Leases peaked at $5.6 million in Q1 2022 and troughed at $285000.0 in Q4 2023.
• A 3-year average of $3.9 million and a median of $4.3 million in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2023: Current Leases fell 4.17% in 2022, then sank 92.95% in 2023.
• A 3-year view of Current Leases shows it stood at $5.5 million in 2021, then dropped by 26.21% to $4.0 million in 2022, then slumped by 92.95% to $285000.0 in 2023.
• Business Quant data shows LENZ's Current Leases at $285000.0 in Q4 2023, $3.4 million in Q3 2023, and $2.9 million in Q2 2023.